NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,640,096 | +7.6% | 720,749 | +176.6% | 0.01% | +20.0% |
| Q2 2023 | $10,815,564 | +1086891.4% | 260,616 | +1474.6% | 0.01% | +400.0% |
| Q1 2023 | $995 | -91.7% | 16,551 | -89.8% | 0.00% | -85.7% |
| Q4 2022 | $11,949 | -95.8% | 162,900 | +4257.9% | 0.01% | – |
| Q3 2022 | $284,000 | -95.1% | 3,738 | -95.5% | 0.00% | -100.0% |
| Q2 2022 | $5,813,000 | +2352.7% | 83,635 | +2827.4% | 0.00% | – |
| Q1 2022 | $237,000 | -97.6% | 2,857 | -97.8% | 0.00% | -100.0% |
| Q4 2021 | $9,738,000 | +2582.6% | 129,698 | +4051.7% | 0.01% | – |
| Q3 2021 | $363,000 | -85.3% | 3,124 | -72.0% | 0.00% | -100.0% |
| Q2 2021 | $2,477,000 | -40.3% | 11,167 | -64.4% | 0.00% | -33.3% |
| Q1 2021 | $4,151,000 | -79.1% | 31,400 | -72.6% | 0.00% | -78.6% |
| Q4 2020 | $19,849,000 | +352.1% | 114,708 | +190.8% | 0.01% | +180.0% |
| Q3 2020 | $4,390,000 | -72.5% | 39,443 | -85.3% | 0.01% | -77.3% |
| Q2 2020 | $15,950,000 | +2392.2% | 268,979 | +2729.6% | 0.02% | +1000.0% |
| Q1 2020 | $640,000 | -60.5% | 9,506 | -56.2% | 0.00% | -33.3% |
| Q3 2019 | $1,622,000 | -57.5% | 21,697 | -64.1% | 0.00% | -50.0% |
| Q2 2019 | $3,820,000 | -34.3% | 60,415 | -49.9% | 0.01% | -33.3% |
| Q1 2019 | $5,811,000 | +775.2% | 120,627 | +852.0% | 0.01% | +800.0% |
| Q3 2018 | $664,000 | -86.2% | 12,671 | -91.7% | 0.00% | -83.3% |
| Q2 2018 | $4,803,000 | -11.0% | 153,465 | -38.0% | 0.01% | -14.3% |
| Q1 2018 | $5,394,000 | -44.9% | 247,424 | -48.9% | 0.01% | -50.0% |
| Q4 2017 | $9,788,000 | +29.6% | 484,569 | +27.4% | 0.01% | +16.7% |
| Q3 2017 | $7,550,000 | +5798.4% | 380,359 | +2302.2% | 0.01% | – |
| Q1 2017 | $128,000 | -76.4% | 15,834 | -75.1% | 0.00% | -100.0% |
| Q3 2016 | $543,000 | +96.7% | 63,527 | +168.2% | 0.00% | 0.0% |
| Q2 2016 | $276,000 | -45.6% | 23,683 | -32.3% | 0.00% | 0.0% |
| Q1 2016 | $507,000 | -59.2% | 35,008 | -37.0% | 0.00% | -66.7% |
| Q4 2015 | $1,243,000 | – | 55,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |